Oruka Therapeutics, Inc. ORKA Issuance of warrants
Issuance of warrants at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s issuance of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s issuance of warrants?
- Oruka Therapeutics, Inc. (ORKA) reported issuance of warrants of $2.52M in Q4 2025.
- How has Oruka Therapeutics, Inc.'s issuance of warrants changed year-over-year?
- Oruka Therapeutics, Inc.'s issuance of warrants decreased by 75.7% year-over-year, from $10.36M to $2.52M.
- What does issuance of warrants mean?
- Represents the accounting adjustments made to additional paid-in capital related to the issuance of warrants. This captures the equity component of financing arrangements that include derivative features.